Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This is a dose-response study to determine how various measurements of airway inflammation
respond to high and low dose FlutiForm®, and compared to placebo.